Product launch strategy for European biopharmaceutical company

Outlook by sectors

Precision oncology and its impact on cancer treatment

Patent Cliff: Can small healthcare firms dictate terms for bigger Pharma on the M&A deals?

Commercial Real Estate Lending Trends: Key Insights

Portfolio remodelling by pharma companies – strategies for sustainable growth

TMT & Healthcare dominate the dealmaking space

Exploring advancement in Genomics in Saudi Arabia – a study of the market landscape

Big pharma’s bet on biotech – key drivers and top focus areas for M&A

The immuno-oncology market – segments, challenges and trends

Telemedicine trends

Evolving life sciences sector

US biotech SPACs at an all-time high; boom likely to continue

Tech firms: finding opportunities in healthcare

Oncology Care Practices: Recent Trends and COVID-19 Impact Analysis

The pharma space after COVID-19 vaccine rollouts, market dynamics and the path of consolidation and fund raising

Impact of COVID-19 on the pharma value chain

Ankush Shaw

Three key themes for the healthcare services space in a post-COVID-19 environment

China’s PD-1 inhibitor market is becoming more competitive